000			01663 a2200469 4500
005			20250516221006.0
264		0	_c20150511
008			201505s 0 0 eng d
022			_a1476-5608
024	7		_a10.1038/pcan.2014.21 _2doi
040			_aNLM _beng _cNLM
100	1		_aSmall, E J
245	0	0	_aTime to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T. _h[electronic resource]
260			_bProstate cancer and prostatic diseases _cSep 2014
300			_a259-64 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnalgesics, Opioid _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCase-Control Studies
650	0	4	_aClinical Trials, Phase III as Topic
650	0	4	_aDisease Progression
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Grading
650	0	4	_aNeoplasm Metastasis
650	0	4	_aPain _xdiagnosis
650	0	4	_aProstatic Neoplasms, Castration-Resistant _xcomplications
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aTime Factors
650	0	4	_aTissue Extracts _xtherapeutic use
700	1		_aHigano, C S
700	1		_aKantoff, P W
700	1		_aWhitmore, J B
700	1		_aFrohlich, M W
700	1		_aPetrylak, D P
773	0		_tProstate cancer and prostatic diseases _gvol. 17 _gno. 3 _gp. 259-64
856	4	0	_uhttps://doi.org/10.1038/pcan.2014.21 _zAvailable from publisher's website
999			_c23945747 _d23945747